NCT07238608 Impact of UFPs and MNPs on Fetal Health
| NCT ID | NCT07238608 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto de Investigacion Sanitaria La Fe |
| Condition | Pregnant Women |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,600 participants in total. It began in 2026-01-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims at unravelling mechanisms by which exposure to air pollution (in particular Ultrafine Particulate (UFP, PM0.1), and micro nano plastic's) interferes with the normal foetus development, with a short-term causal effect in higher likeliness of preterm delivery which, in consequence, precondition a higher likeliness to suffer non-communicable diseases (NCD) later in the life.
Eligibility Criteria
Inclusion Criteria: * Agreement to sign the informed consent; * Non-smoking mothers and no exposure to environmental (second-hand) smoke (smoking influences UFP measurements); * ≥18 years old (mothers have to place sensors, mothers with childhood pregnancies may live at their parental home); * Not expecting to terminate the pregnancy (no measurements of the child); * Having resided in the geographical area of research for a minimum period of 1 year (to be eligible for modeling exposures). Exclusion Criteria: * First visit after 11 weeks of gestation (to ensure 2-week monitoring in the first trimester); * Pregnancy complications that limit exposure measurements in urine (because it may cause polyuria, for example, gestational diabetes); * Known kidney disease (might influence exposure measurements in urine); * Multiple pregnancy (twin or more pregnancies may have a higher risk for complications or preterm birth, no measurements in the last trimester).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07238608 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnant Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07238608 currently recruiting?
Yes, NCT07238608 is actively recruiting participants. Contact the research team at alba_ruiz@externos.iislafe.es for enrollment information.
Where is the NCT07238608 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT07238608 clinical trial?
NCT07238608 is sponsored by Instituto de Investigacion Sanitaria La Fe. The trial plans to enroll 1,600 participants.